Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung disease
Journal
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Journal Volume
27
Journal Issue
3
Date Issued
2021-03
Author(s)
Abstract
Disease progression is a strong indicator of treatment for Mycobacterium avium complex lung disease (MAC-LD). The impact of MAC subspecies on the risk of disease progression remains uncertain in MAC-LD patients.
Subjects
Disease progression; Mycobacterium aviumcomplex (MAC); Non-tuberculous Mycobacterium(NTM); Prediction; Subspecies identification
SDGs
Other Subjects
azithromycin; clarithromycin; DNA 23S; DNA fragment; internal transcribed spacer; RNA polymerase; aged; antibiotic therapy; Article; atypical mycobacteriosis; bacterium isolate; body mass; cohort analysis; comorbidity; controlled study; coughing; diabetes mellitus; disease course; disease exacerbation; DNA extraction; dyspnea; female; follow up; gene mutation; genotype; hemoptysis; human; incidence; lung infection; major clinical study; male; Mycobacterium avium complex; Mycobacterium chimaera; Mycobacterium intracellulare; nonhuman; polymerase chain reaction; priority journal; retrospective study; sputum smear; subspecies; atypical mycobacteriosis; genetics; lung disease; microbiology; middle aged; Mycobacterium avium complex; pathology; very elderly; Aged; Aged, 80 and over; Cohort Studies; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies
Type
journal article